ICSMA-22-263-01
Vulnerability from csaf_cisa - Published: 2022-09-20 00:00 - Updated: 2022-09-20 00:00Summary
Medtronic NGP 600 Series Insulin Pumps
Notes
CISA Disclaimer
This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov
Legal Notice
All information products included in https://us-cert.cisa.gov/ics are provided "as is" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.
Risk evaluation
Successful exploitation of this vulnerability could allow an unauthorized user to deliver too much or too little insulin through delivery of an unintended insulin bolus or because insulin delivery is slowed or stopped.
Critical infrastructure sectors
Healthcare and Public Health
Countries/areas deployed
Worldwide
Company headquarters location
Ireland
Recommended Practices
CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.
Recommended Practices
CISA also provides a section for control systems security recommended practices on the ICS webpage at cisa.gov/ics. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Recommended Practices
Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents.
Recommended Practices
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov/ics in the technical information paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.
Exploitability
No known public exploits specifically target this vulnerability. This vulnerability has a high attack complexity.
{
"document": {
"acknowledgments": [
{
"organization": "Medtronic",
"summary": "identifying and reporting this vulnerability to CISA"
}
],
"category": "csaf_security_advisory",
"csaf_version": "2.0",
"distribution": {
"text": "Disclosure is not limited",
"tlp": {
"label": "WHITE",
"url": "https://us-cert.cisa.gov/tlp/"
}
},
"lang": "en-US",
"notes": [
{
"category": "general",
"text": "This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov",
"title": "CISA Disclaimer"
},
{
"category": "legal_disclaimer",
"text": "All information products included in https://us-cert.cisa.gov/ics are provided \"as is\" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.",
"title": "Legal Notice"
},
{
"category": "summary",
"text": "Successful exploitation of this vulnerability could allow an unauthorized user to deliver too much or too little insulin through delivery of an unintended insulin bolus or because insulin delivery is slowed or stopped.",
"title": "Risk evaluation"
},
{
"category": "other",
"text": "Healthcare and Public Health",
"title": "Critical infrastructure sectors"
},
{
"category": "other",
"text": "Worldwide",
"title": "Countries/areas deployed"
},
{
"category": "other",
"text": "Ireland",
"title": "Company headquarters location"
},
{
"category": "general",
"text": "CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.",
"title": "Recommended Practices"
},
{
"category": "general",
"text": "CISA also provides a section for control systems security recommended practices on the ICS webpage at cisa.gov/ics. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.",
"title": "Recommended Practices"
},
{
"category": "general",
"text": "Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents.",
"title": "Recommended Practices"
},
{
"category": "general",
"text": "Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov/ics in the technical information paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.",
"title": "Recommended Practices"
},
{
"category": "other",
"text": "No known public exploits specifically target this vulnerability. This vulnerability has a high attack complexity.",
"title": "Exploitability"
}
],
"publisher": {
"category": "coordinator",
"contact_details": "Email: CISAservicedesk@cisa.dhs.gov;\n Toll Free: 1-888-282-0870",
"name": "CISA",
"namespace": "https://www.cisa.gov/"
},
"references": [
{
"category": "self",
"summary": "ICS Advisory ICSMA-22-263-01 JSON",
"url": "https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2022/icsma-22-263-01.json"
},
{
"category": "self",
"summary": "ICS Advisory ICSMA-22-263-01 Web Version",
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-263-01"
},
{
"category": "external",
"summary": "Recommended Practices",
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-263-01"
},
{
"category": "external",
"summary": "Recommended Practices",
"url": "https://us-cert.cisa.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf"
}
],
"title": "Medtronic NGP 600 Series Insulin Pumps",
"tracking": {
"current_release_date": "2022-09-20T00:00:00.000000Z",
"generator": {
"engine": {
"name": "CISA CSAF Generator",
"version": "1.0.0"
}
},
"id": "ICSMA-22-263-01",
"initial_release_date": "2022-09-20T00:00:00.000000Z",
"revision_history": [
{
"date": "2022-09-20T00:00:00.000000Z",
"legacy_version": "Initial",
"number": "1",
"summary": "Publication Date"
}
],
"status": "final",
"version": "1"
}
},
"product_tree": {
"branches": [
{
"branches": [
{
"branches": [
{
"category": "product_version",
"name": "MMT-1710",
"product": {
"name": "MiniMed 620G: MMT-1710",
"product_id": "CSAFPID-0001"
}
}
],
"category": "product_name",
"name": "MiniMed 620G"
},
{
"branches": [
{
"category": "product_version",
"name": "MMT-1715 | MMT-1754 | MMT-1755",
"product": {
"name": "MiniMed 630G: MMT-1715 MMT-1754 MMT-1755",
"product_id": "CSAFPID-0002"
}
}
],
"category": "product_name",
"name": "MiniMed 630G"
},
{
"branches": [
{
"category": "product_version",
"name": "MMT-1711 | MMT-1712 | MMT-1751 | MMT-1752",
"product": {
"name": "MiniMed 640G: MMT-1711 MMT-1712 MMT-1751 MMT-1752",
"product_id": "CSAFPID-0003"
}
}
],
"category": "product_name",
"name": "MiniMed 640G"
},
{
"branches": [
{
"category": "product_version",
"name": "MMT-1740 | MMT-1741 | MMT-1742 | MMT-1760 | MMT-1762 | MMT-1762 | MMT-1780 | MMT-1781 | MMT-1782",
"product": {
"name": "MiniMed 670G: MMT-1740 MMT-1741 MMT-1742 MMT-1760 MMT-1762 MMT-1762 MMT-1780 MMT-1781 MMT-1782",
"product_id": "CSAFPID-0004"
}
}
],
"category": "product_name",
"name": "MiniMed 670G"
}
],
"category": "vendor",
"name": "Medtronic"
}
]
},
"vulnerabilities": [
{
"cve": "CVE-2022-32537",
"cwe": {
"id": "CWE-693",
"name": "Protection Mechanism Failure"
},
"notes": [
{
"category": "summary",
"text": "A vulnerability exists which could allow an unauthorized user to learn aspects of the communication protocol used to pair system components while the pump is being paired with other system components. Exploitation requires nearby wireless signal proximity with the patient and the device; advanced technical knowledge is required for exploitation.CVE-2022-32537 has been assigned to this vulnerability. A CVSS v3 base score of 4.8 has been calculated; the CVSS vector string is (AV:A/AC:H/PR:L/UI:N/S:U/C:N/I:H/A:N).",
"title": "Vulnerability Summary"
}
],
"product_status": {
"known_affected": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004"
]
},
"references": [
{
"category": "external",
"summary": "web.nvd.nist.gov",
"url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2022-32537"
},
{
"category": "external",
"summary": "www.first.org",
"url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:A/AC:H/PR:L/UI:N/S:U/C:N/I:H/A:N"
}
],
"remediations": [
{
"category": "vendor_fix",
"details": "Medtronic recommends users to take the following actions:",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004"
]
},
{
"category": "vendor_fix",
"details": "Note: Turning off the remote bolus feature will ensure no remote bolus is possible.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004"
]
},
{
"category": "vendor_fix",
"details": "Medtronic has identified the following precautions to assist users:",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004"
]
}
],
"scores": [
{
"cvss_v3": {
"baseScore": 4.8,
"baseSeverity": "MEDIUM",
"vectorString": "CVSS:3.0/AV:A/AC:H/PR:L/UI:N/S:U/C:N/I:H/A:N",
"version": "3.0"
},
"products": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004"
]
}
]
}
]
}
Loading…
Loading…
Sightings
| Author | Source | Type | Date |
|---|
Nomenclature
- Seen: The vulnerability was mentioned, discussed, or observed by the user.
- Confirmed: The vulnerability has been validated from an analyst's perspective.
- Published Proof of Concept: A public proof of concept is available for this vulnerability.
- Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
- Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
- Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
- Not confirmed: The user expressed doubt about the validity of the vulnerability.
- Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.
Loading…
Loading…